OBJECTIVE: To characterize the treatments and short-term outcomes in infants with severe bronchopulmonary dysplasia (sBPD) referred to regional neonatal intensive care units. STUDY DESIGN: Infants born o32 weeks' gestation with sBPD were identified using the Children's Hospital Neonatal Database. Descriptive outcomes are reported. RESULT: A total of 867 patients were eligible. On average, infants were born at 26 weeks' gestation and referred 43 days after birth. Infants frequently experienced lung injury (pneumonia: 24.1%; air leak: 9%) and received systemic corticosteroids (61%) and mechanical ventilation (median duration 37 days). Although 91% survived to discharge, the mean post-menstrual age was 47 weeks. Ongoing care such as supplemental oxygen (66%) and tracheostomy (5%) were frequently needed. CONCLUSION: Referred infants with sBPD sustain multiple insults to lung function and development. Because affected infants have no proven, safe or efficacious therapy and endure an exceptional burden of care even after referral, urgent work is required to observe and improve their outcomes.
INTRODUCTION
Severe bronchopulmonary dysplasia (sBPD) occurs mainly in infants born o32 weeks' gestation; 1 it is an important morbidity because its presence is highly associated with cerebral palsy and neurodevelopmental deficits in early childhood. [2] [3] [4] [5] These adverse outcomes highlight the need for further research to focus on both the co-morbid conditions that frequently accompany sBPD as well as potential therapies to improve the care and outcomes for affected infants. 5, 6 With a validated definition and reported prevalence of 19% among extremely low birth weight infants, 1, 7 prematurity-associated sBPD has proven challenging to study because single neonatal intensive care units (NICUs) have few patients who develop this condition. Infants with sBPD are commonly referred to institutions when specialized pediatric services are required. However, even in a referral-based regional NICU, 8 patient volume is usually insufficient to associate infrequent morbidities and interventions to specific outcomes. To capture a representative cohort, years may elapse and both interventions and outcomes may evolve. Thus, the currently used therapies and outcomes in this population of infants with sBPD remain ill defined.
Although some strategies reduce the incidence of bronchopulmonary dysplasia (BPD), 9 other secondary efforts such as inhaled nitric oxide 10, 11 or corticosteroids 12, 13 have uncertain benefit once BPD, and particularly sBPD, is established. The therapies associated with the prevention of BPD such as inhaled nitric oxide or corticosteroids have not been systematically tested in a population of infants with established sBPD in order to reduce rates of subsequent morbidities. [13] [14] [15] To hypothesize which therapies may offer benefit or induce harm in infants with sBPD, the characteristics of the population, their outcomes, as well as the interventions they receive must be described. 6 Moreover, descriptions of the care provided and achieved outcomes are needed to assist clinicians to counsel parents/families.
The purpose of this work is to focus on a referred population of infants with sBPD who were cared for at children's hospitals' NICUs. The aims of this study are to characterize mortality, length of stay, and the use of selected interventions/medications, and secondarily, to describe in-hospital outcomes and prevalence of prematurity-associated morbidities in this large, multi-center contemporary cohort with sBPD.
METHODS
The Children's Hospital Neonatal Database (CHND) prospectively captured clinical data on all infants admitted to 24 participating regional NICUs. Chart abstractors at each site underwent prospective training including review of clinical definitions, participation in web-based seminar tutorials, case-based practice. Both initial and bi-annual measurements of inter-rater agreement scores were calculated at each site; over 90% intra-site concordance in abstraction is required for initial and continued participation in the CHND. 16 For the current study, the CHND was accessed on 6-18-12 to identify infants who had sBPD and who were born o32 weeks' gestational age (GA) in 2010-2011. Prospectively, sBPD was defined as infants who were either receiving positive pressure, nasal cannula flowX2 liters-per-minute, or delivered FiO 2 X0.30 at 36 weeks' post-menstrual age (PMA). Infants were excluded if either GA at birth or respiratory status at 36 weeks' PMA was unknown. This definition of sBPD was modified from a previously validated definition in two ways. 1 First, because referral to the regional NICU 8 occurred well after birth and sometimes well after 36 weeks' PMA for many infants, the documentation of receipt of 28 days of oxygen before 36 weeks' PMA was often unavailable and, consequently, was not included as a criteria for sBPD. Second, receipt of high-flow nasal cannula support was included in the case definition of sBPD given the observed correlation between high-flow rates and delivered positive airway pressure. 17, 18 The main outcomes before discharge included mortality, selected medication use including corticosteroids and the provisions of respiratory care were reported for all eligible infants. In addition to mortality, length of stay in the CHND NICU was reported and stratified by mortality before discharge. For infants born p27 6/7 weeks' GA, the trends in the provisions of respiratory care, analgesia (with opiates) and sedation (with benzodiazepines, BZ) are reported at specific dates during the infants' hospitalizations. The selected time points were at admission, 36, 40, 44 and 48 weeks' PMA, and at discharge home/death. Information was ascertained only if infants were hospitalized in the NICU.
Infants are described using maternal and infant demographic, birth and clinical characteristics, and are stratified by GA at birth: p27 6/7 and 28 0/7 to 31 6/7 weeks' GA. Because over 90% of infants were born outside the participating CHND hospitals, selected variables that depict the clinical course before referral to the regional NICU are summarized. These included obstetric factors, the primary reason for referral and the prevalence of selected prematurity-associated morbidities that were present at the time of referral.
In order to describe the severity of pulmonary illness in this cohort, the delivered respiratory care was reported and classified as conventional, high-frequency oscillatory and jet ventilation, non-invasive intermittent positive pressure support, nasal cannula support including the flow rate and/or delivered FiO 2 . If positive pressure was being provided, then both the mean airway pressure and delivered FiO 2 were also captured. The highest mean airway pressure and delivered FiO 2 that each infant received for the majority of the 24-h period of the key time point were collected. Also, the receipt and indication(s) of corticosteroids were described.
Secondarily, other descriptors, short-term outcomes and medication use were also reported. Small for GA was defined as the gender-specific birth weight p10th percentile for GA. 19 For infants referred from another NICU, the level of neonatal care 20 at the referring NICU was reported based on its known designation in the CHND. Morbidities present on admission were assigned based on admission diagnoses and/or prematurity-associated co-morbidities existing at the time of referral in accordance with standard neonatal definitions. Blood stream infection (BSI) and central lineassociated BSIs were reported as: (1) the proportion of infants who had either of these infections at any time during their CHND hospitalization and (2) the rate per 1000 patient days and central venous line days for BSI and central line-associated BSI, respectively. 21 Retinopathy of prematurity was assigned independently as per the treating ophthalmologist. Pneumonia was determined by a clinical diagnosis as assigned by the clinical team and with anti-microbial treatment for at least 7 days. Necrotizing enterocolitis was defined per established definitions based on clinical symptoms and radiographic changes, whereas surgical necrotizing enterocolitis required the presence of pneumoperitoneum and/or surgical intervention. 6 Finally, other medications that were of interest were opiates included hydrocodone, methadone, codeine, oxycodone, morphine or fentanyl received on the pre-specified day of interest. BZs included midazolam, lorazepam, klonazepam and diazepam. Continuous infusions, scheduled and pro re nata doses were all included for these medications. Postoperative medication administration was not counted if the key time point fell within 3 days of the surgical procedure.
Data description and analyses were performed with SAS v9.3. Student's t-test and w 2 were applied, as appropriate. Non-parametric testing was applied when the distribution of selected measures did not conform to a normal distribution. The Children's Hospital of Chicago Research Center's Institutional Review Board approved this study (#2011-14673).
RESULTS
Of 25 175 infants in the CHND, 867 (3.4%) infants were born o32 weeks' GA and also met the case definition for sBPD. The majority (79%) of infants with sBPD were born p27 6/7 weeks' GA. Relative to the national birth cohort, 21 male (63%), black (35%), small for GA 19 (21.8%) and multiple gestation (23%) infants are overrepresented, along with those who were born after chorioamnionitis was present (10.3%). Also, 92% of infants were born outside a CHND hospital or an adjacent obstetric center, and 71% were referred after receiving care in another Level III NICU. 8 Three-quarters received mechanical ventilation upon referral to the regional NICU participating in CHND. Also, over half (53%) were referred for management of their respiratory disease or for surgical evaluation or management of their health problems. Onequarter of the infants had an established diagnosis of BPD (supplemental oxygen at 36 weeks' PMA) at the time of referral. Other characteristics are reported in Table 1 .
After referral, this cohort received multiple pulmonary treatments, and in Supplementary Table 1, these treatments are described in order to reflect the illness severity of the cohort. Although caffeine and vitamin A were frequently administered to the most immature infants born p27 weeks' GA, both nasal CPAP (P ¼ 0.038) and surfactant administration (P ¼ 0.003) after referral were used more frequently in infants born 28 to 31 6/7 weeks' GA. In addition, 12% and 19% of infants received inhaled nitric oxide before and after referral, respectively. The utilization and the indications for prescribing corticosteroids are summarized. 22 After referral, 72% of infants with sBPD received any steroid medication, which was more frequent in the more immature GA stratum (P ¼ 0.013).
Overall, 9% (n ¼ 78) of infants with sBPD died before CHND hospital discharge. Among survivors, the median length of hospitalization after referral was 105 days (interquartile range (IQR): 70, 145), corresponding to mean PMA at discharge of 47 ± 8 weeks. In contrast, non-survivors were hospitalized for a median of 72 days (IQR: 45, 126) and died at a mean PMA of 50 ± 11 weeks (P ¼ 0.04). In addition, the median duration of mechanical ventilation was significantly shorter among survivors (35 days (IQR: 12, 64 days)) relative to non-survivors (51 days (IQR 25, 99 days), Po0.001). The three most frequent primary causes of death in non-survivors were respiratory failure (51%), multi-organ system failure (19%) and congenital anomalies or syndromes (8%).
Relative to infants of more advanced gestation, there was a significant increase in survival to discharge from the NICU among infants born p27 weeks (93.4% vs 83.7%, Po0.01) even though their median length of hospitalization after referral was significantly longer (110 days vs 79 days, Po0.01).
Prematurity-associated co-morbidities and secondary outcomes before discharge from the NICU are reported (Table 2) . At the time of discharge, 66% of the surviving sBPD infants were prescribed supplemental oxygen, 68% went home with non-invasive monitoring, whereas 5.3% underwent tracheostomy placement. These interventions were similar between GA strata and occurred at similar PMA in the two strata ( Table 2) .
The types and levels of respiratory support during the hospitalizations at varied time points are summarized in Supplementary  Table 2 . At the time of referral, 84% received a form of positive pressure respiratory support. Of those who remained hospitalized, the proportion that received positive pressure support decreased until 40 weeks' PMA. The mean delivered FiO 2 did not significantly change for those who remained hospitalized, although many infants were discharged from the NICU between these selected time points. Similarly, the most immature infants commonly received opiates and BZs; however, barbiturates were used infrequently (2.4%, all time points). Of note, opiates and/or BZs were administered to 43% of eligible infants at the time of referral (Supplementary Table 2 ). Few patients received these medications when being discharged home (2.4%).
DISCUSSION
In a large, modern, multi-center cohort of infants with sBPD, this study demonstrates that affected infants who were cared for in regional NICUs frequently were many weeks old and had evolving or established chronic pulmonary disease at the time of referral. On average, these infants were hospitalized for more than 3 months after referral, but still had a high survival rate to discharge. In addition, this study delineates the use of multiple therapies during their lengthy hospitalizations-many of which have uncertain safety or efficacy profiles-and describes their inhospital outcomes in these participating regional NICUs.
Infants in this cohort were frequently born of multiple gestation pregnancies, were small for GA and at least 1 in 10 were exposed to chorioamnionitis; these findings are consistent with existing work suggesting an association between BPD and an unfavorable intrauterine environment, 4, 23 and even a different biological mechanism for developing sBPD. 24 In addition, these infants frequently had significant morbidities already existing at the time of referral to the regional NICU. In combination, these biological influences, the acquired morbidities and the effects of treatments likely interacted to result in the observed outcomes. On average, these infants receive over 5 weeks of mechanical ventilation and a delivered FiO 2 of approximately 50% if they remained hospitalized. In addition, a majority (66%) of infants discharged directly home from the CHND NICU also were receiving supplemental oxygen at discharge. Although the oxygen saturation targets in each NICU were not collected, 25 these data suggest that pulmonary dysfunction was marked and slow to improve for these infants.
In this large cohort of infants all of whom were ultimately cared for in regional NICUs, the overall severity of pulmonary disease is likely more pronounced than that described in prior preterm cohorts with BPD. 6, 7 Consequently, these infants likely may have received more interventions directed toward their sBPD. One such therapy used frequently in our cohort was systemic corticosteroids, which has been shown to both decrease rates and severity of chronic lung disease and decrease time on mechanical ventilation. 26 However, steroids can have direct adverse effects on the developing brain and early postnatal steroid use in very preterm infants has been associated with adverse, neurodevelopmental outcomes, particularly cerebral palsy. 12 Independent of steroid exposure, the presence of BPD itself confers a risk of adverse neurodevelopment and this risk is amplified in those with more severe BPD. 15 Thus, steroid administration in some infants may improve overall outcomes if BPD rates or severity are decreased. In an elegant meta-analysis by Doyle et al., it appeared that when risk of chronic lung disease rose above 65%, steroid use significantly reduced the risk of death or cerebral palsy, whereas the opposite effect was seen when chronic lung disease risk was less than 35%. In high-risk cohorts with sBPD such as described here, the point at which the risk of steroid use may outweigh benefit urgently warrants further investigation so that this therapy can be used appropriately and with effectiveness. 15, 27, 28 This analysis also starts to define the frequency of exposure to opiates and/or BZs in the most preterm infants in this cohort, despite limited data supporting their safety or benefit in preterm infants. 29, 30 Also, both human and animal models have demonstrated an adverse association with future neurodevelopment with the use of these medications. Moreover, this study measures these exposures during a critical time in brain development in this large cohort of infants. 31 Although the indications for prescribing opiates and/or BZs were unmeasured, we speculate that the rationale underlying their use was not targeted toward improving pulmonary growth or development but for the maintenance of adequate ventilation and oxygenation. Further work is needed to determine the indications and the outcomes related to these practices.
There are several limitations of this study. This cohort was referred to regional NICUs may not be representative of the entire population of preterm infants with sBPD; it is plausible that the infants who were most likely to develop sBPD were referred to these NICUs. In addition, most infants had significant respiratory and other morbidities established before referral. Nevertheless, this report summarizes the therapies received and the short-term outcomes of a large, contemporary, US-born cohort of infants with sBPD referred to children's hospitals' NICUs. These data allow Reasons include cardiac, retinopathy of prematurity, infection, failure to thrive, vascular access, congenital anomaly, hematologic-oncologic, bilirubin pathology, disorders of metabolism and other.
clinicians to have more contemporary and representative information when counseling families whose infants develop sBPD.
As in any analysis of secondary data, unknown and unmeasured factors could have modified the observed associations and coding errors leading to misclassifications are a possibility. However, proactive steps were taken to reduce the chance of misclassifications. Before participation, abstractors were educated in the clinical aspects of the collected variables and in the procedures for data collection. In addition, inter-rater agreement scores were serially assessed until thresholds were consistently met within each participating site. Consequently, the risk of systematic measurement errors was diminished and was unlikely to significantly alter the reported results.
In summary, this study describes a large, multicenter, high-risk cohort of infants with pulmonary sequelae using a novel data source that focused on referral-based, regional neonatal intensive care. These results can be used to assist in counseling families of affected, referred infants and to facilitate a greater understanding of the burden these infants face once their pulmonary disease is severe. Although individual hypotheses were not tested in this descriptive study, these data will serve to generate hypotheses on which future prospective clinical studies could be based. This descriptive case series characterize the short-term outcomes in a population of infants with sBPD referred to regional NICUs and affirm that sBPD must be a focus of further research in order to develop preventive and therapeutic regimens.
CONFLICT OF INTEREST
A portion of Ms Asselin's salary was provided by Children's Hospital Association, Inc., for the development and maintenance of the database that was analyzed for this study. The remaining authors declare no conflict of interest. Measured by first ECHO after referral at 7 ± 9 weeks of age and 526/683 and 147/184 infants in each of the GA stratum had ECHOs after referral. PDA was coded if any 'non-trial' flow was noted at the ductus. 8.7% of all infants who had an ECHO had missing information regarding ductal flow.
b Defined as right ventricular dilation.
